Jossie Rotman

429 total citations
10 papers, 324 citations indexed

About

Jossie Rotman is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Jossie Rotman has authored 10 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in Jossie Rotman's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers) and Cervical Cancer and HPV Research (3 papers). Jossie Rotman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers) and Cervical Cancer and HPV Research (3 papers). Jossie Rotman collaborates with scholars based in Netherlands, United States and Belgium. Jossie Rotman's co-authors include Tanja D. de Gruijl, Ekaterina S. Jordanova, A. Marijne Heeren, Gemma G. Kenter, Henry Zijlmans, Maaike C.G. Bleeker, Sanne Samuels, Bas D. Koster, Constantijne H. Mom and Zvi Nevo and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Jossie Rotman

10 papers receiving 317 citations

Peers

Jossie Rotman
Bas D. Koster Netherlands
D-A Silasi United States
Heidi Godoy United States
Kristen Bunch United States
Jossie Rotman
Citations per year, relative to Jossie Rotman Jossie Rotman (= 1×) peers Rosario García‐Rocha

Countries citing papers authored by Jossie Rotman

Since Specialization
Citations

This map shows the geographic impact of Jossie Rotman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jossie Rotman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jossie Rotman more than expected).

Fields of papers citing papers by Jossie Rotman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jossie Rotman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jossie Rotman. The network helps show where Jossie Rotman may publish in the future.

Co-authorship network of co-authors of Jossie Rotman

This figure shows the co-authorship network connecting the top 25 collaborators of Jossie Rotman. A scholar is included among the top collaborators of Jossie Rotman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jossie Rotman. Jossie Rotman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rotman, Jossie, Oscar R. Brouwer, Henk G. van der Poel, et al.. (2022). Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis. Journal of Clinical Medicine. 11(4). 1101–1101. 17 indexed citations
2.
Bakker, Noor A. M., Jossie Rotman, Marc van Beurden, et al.. (2021). HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial. Journal for ImmunoTherapy of Cancer. 9(8). e002547–e002547. 12 indexed citations
3.
Griffin, Heather, Maaike C.G. Bleeker, Renske D.M. Steenbergen, et al.. (2021). Delta-Like Ligand–Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis. Cancer Research. 81(7). 1909–1921. 22 indexed citations
4.
Heeren, A. Marijne, Jossie Rotman, Sanne Samuels, et al.. (2021). Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth. Journal for ImmunoTherapy of Cancer. 9(10). e003623–e003623. 22 indexed citations
5.
Rotman, Jossie, A. Marijne Heeren, Sinéad M. Lougheed, et al.. (2020). Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma. Clinical Cancer Research. 26(14). 3791–3802. 21 indexed citations
6.
Rotman, Jossie, Maaike C.G. Bleeker, Sanne Samuels, et al.. (2020). PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential. Frontiers in Immunology. 11. 596825–596825. 68 indexed citations
7.
Rotman, Jossie, Bas D. Koster, Ekaterina S. Jordanova, A. Marijne Heeren, & Tanja D. de Gruijl. (2019). Unlocking the therapeutic potential of primary tumor-draining lymph nodes. Cancer Immunology Immunotherapy. 68(10). 1681–1688. 57 indexed citations
8.
Heeren, A. Marijne, Jossie Rotman, Anita G.M. Stam, et al.. (2019). Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels. Journal for ImmunoTherapy of Cancer. 7(1). 43–43. 44 indexed citations
9.
Rotman, Jossie, Constantijne H. Mom, Ekaterina S. Jordanova, Tanja D. de Gruijl, & Gemma G. Kenter. (2018). ‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment. BMC Cancer. 18(1). 888–888. 27 indexed citations
10.
Pras, Mordechai, et al.. (1971). THE SIGNIFICANCE OF MUCOPOLYSACCHARIDES IN AMYLOID. Journal of Histochemistry & Cytochemistry. 19(7). 443–448. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026